Clinical Trial Detail

NCT ID NCT01099358
Title Study in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

Therapies

Cetuximab + Cisplatin

Fluorouracil

Age Groups: adult

No variant requirements are available.